Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
21 October 2014Website:
http://avanos.comNext earnings report:
20 February 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 01 Nov 2024 21:59:02 GMTDividend
Analysts recommendations
Institutional Ownership
AVNS Latest News
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Avanos Medical, Inc. AVNS reported third-quarter 2024 adjusted earnings per share (EPS) from continuing operations of 36 cents, up 20% year over year. The bottom line met the Zacks Consensus Estimate.
Avanos Medical Inc. (NYSE:AVNS ) Q3 2024 Results Conference Call October 30, 2024 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy & Corporate Development Gary Blackford - Chairman Michael Greiner - Senior VP, CFO & Chief Transformation Officer Conference Call Participants Kristen Stewart - CL King Danny Stauder - Citizens JMP Operator Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos Third Quarter 2024 Earnings Call. [Operator Instructions] This call is being recorded on Wednesday, October 30, 2024.
Avanos Medical (AVNS) came out with quarterly earnings of $0.36 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.30 per share a year ago.
ALPHARETTA, Ga. , Oct. 23, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2024 on Wednesday, Oct. 30 at 9 a.m.
Avanos Medical (AVNS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
AVNS's strong product line and focus on R&D raise optimism about the stock.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
AVNS' GAME READY announces a paid partnership with NFL defensive end and San Francisco 49ers star, Nick Bosa.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
What type of business is Avanos Medical?
Avanos Medical, Inc. offers a wide range of products focused on respiratory and digestive health; pain management solutions; as well as minimally invasive interventional methods for pain treatment, closed suction systems for airways, and enteral feeding tubes. The company also offers Game Ready products for pain relief and rehabilitation of patients recovering from orthopedic surgeries or sports injuries; GRPro 2.1 cold and compression therapy system; Med4Elite, a multimodal therapy block; ATX wraps; and various accessories for products. Additionally, it sells its products under the brands ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and GAME READY. Avanos Medical, Inc. was registered in 2014 and is headquartered in Alpharetta, Georgia.
What sector is Avanos Medical in?
Avanos Medical is in the Healthcare sector
What industry is Avanos Medical in?
Avanos Medical is in the Medical Devices industry
What country is Avanos Medical from?
Avanos Medical is headquartered in United States
When did Avanos Medical go public?
Avanos Medical initial public offering (IPO) was on 21 October 2014
What is Avanos Medical website?
https://avanos.com
Is Avanos Medical in the S&P 500?
No, Avanos Medical is not included in the S&P 500 index
Is Avanos Medical in the NASDAQ 100?
No, Avanos Medical is not included in the NASDAQ 100 index
Is Avanos Medical in the Dow Jones?
No, Avanos Medical is not included in the Dow Jones index
When was Avanos Medical the previous earnings report?
No data
When does Avanos Medical earnings report?
The next expected earnings date for Avanos Medical is 20 February 2025